Vita Coco (NASDAQ: COCO) chair’s trust sells 50,000 shares under 10b5-1 plan

Rhea-AI Filing Summary

Vita Coco Company, Inc. Executive Chairman Michael Kirban, through the Michael Kirban Revocable Trust, sold 50,000 shares of common stock in open-market transactions at $58 per share on March 11–12, 2026 under a Rule 10b5-1 trading plan. Following these sales, the filing shows continued indirect ownership of 565,681 shares in that trust, additional indirect holdings in the Michael Kirban 2010 Trust, direct ownership of common stock, and multiple fully vested and time-vesting stock options covering substantial additional shares.

Insights

Insider trading and governance analyst

Pre-planned trust sales of 50,000 shares look routine given the large remaining position.

Executive Chairman Michael Kirban reported open-market sales of 50,000 shares of Vita Coco common stock at $58 per share over March 11–12, 2026. The transactions were executed by the Michael Kirban Revocable Trust pursuant to a Rule 10b5-1 trading plan.

Rule 10b5-1 plans are pre-arranged trading programs, which generally signal planned liquidity rather than opportunistic timing. After these sales, the trust still holds 565,681 shares, while other trusts and direct accounts hold additional common stock, indicating a sizable remaining equity stake.

The filing also lists several non-qualified stock option awards with exercise prices between $10.178 and $32.7800 expiring from 2029 through 2035, many of which are fully vested or vest annually. These options give Kirban further leveraged exposure to the company’s share price alongside his direct and indirect shareholdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kirban Michael

(Last) (First) (Middle)

111 5TH AVENUE

2ND FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/11/2026		S(1)		9,796	D	$58	605,885	I	by M. Kirban Revoc(2)
Common Stock	03/12/2026		S(1)		40,204	D	$58	565,681	I	by M. Kirban Revoc(2)
Common Stock								143,799	D
Common Stock								1,479,049	I	by M. Kirban 2010(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy)	$10.178							(4)	12/16/2029	Common Stock	546,000		546,000	D
Non-Qualified Stock Option (Right to Buy)	$10.178							(4)	01/11/2031	Common Stock	40,950		40,950	D
Non-Qualified Stock Option (Right to Buy)	$15							(5)	10/21/2031	Common Stock	298,507		298,507	D
Non-Qualified Stock Option (Right to Buy)	$16.91							(6)	03/10/2033	Common Stock	46,875		46,875	D
Non-Qualified Stock Option (Right to Buy)	$16.91							(4)	03/10/2033	Common Stock	185,133		185,133	D
Non-Qualified Stock Option (Right to Buy)	$26.18							(7)	03/04/2034	Common Stock	62,743		62,743	D
Non-Qualified Stock Option (Right to Buy)	$32.78							(8)	03/03/2035	Common Stock	70,715		70,715	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. These shares are held by the Michael Kirban Revocable Trust.

3. These shares are held by the Michael Kirban 2010 Trust.

4. The stock option is fully vested and currently exercisable.

5. The stock option vests in four equal annual installments beginning on November 27, 2022.

6. The stock option vests in four equal annual installments beginning on March 10, 2024.

7. The stock option vests in four equal annual installments beginning on March 4, 2025.

8. The Stock Option vests in four equal annual installments beginning in March 3, 2026.

	Alison Klein, attorney-in-fact for Michael Kirban	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Vita Coco (COCO) report for Michael Kirban?

Vita Coco reported that Executive Chairman Michael Kirban’s revocable trust sold 50,000 shares of common stock in open-market transactions at $58 per share. The sales occurred on March 11–12, 2026 and were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.

Were Michael Kirban’s COCO share sales made under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan. Such plans are established in advance and allow scheduled transactions, which typically indicates planned diversification or liquidity rather than discretionary, market-timed selling by the insider or related trust.

How many Vita Coco shares does Michael Kirban’s revocable trust hold after the sale?

After selling 50,000 shares, the Michael Kirban Revocable Trust holds 565,681 Vita Coco common shares. The Form 4 also shows additional indirect holdings in the Michael Kirban 2010 Trust and separate direct holdings, so the reported sale represents only a portion of Kirban’s overall position.

Does Michael Kirban still hold Vita Coco (COCO) stock options after this Form 4?

Yes. The filing lists several non-qualified stock options on Vita Coco common stock with exercise prices from $10.178 to $32.7800 and expirations between 2029 and 2035. Footnotes indicate some options are fully vested while others vest annually over four-year schedules.

Is the COCO share sale attributed personally to Michael Kirban or to a trust?

The 50,000-share sale is attributed to the Michael Kirban Revocable Trust, an entity associated with Kirban. The Form 4 notes these shares are held by that trust, and Kirban is the reporting person for indirect ownership, rather than selling the shares directly in his own name.

What does this Form 4 suggest about Michael Kirban’s remaining stake in Vita Coco?

The Form 4 shows Kirban retains substantial exposure to Vita Coco through indirect holdings in two trusts, direct common stock ownership, and multiple option grants. Despite the 50,000-share sale, the disclosed remaining trust position alone totals 565,681 shares, plus other reported holdings and options.